Russia may authorize compulsory licensing of medicinal products this year

Print 12 July 2017
GMP News

The procedure for compulsory licensing of drugs may be introduced in Russia as early as this year, said Igor Artemyev, the Head of the Federal Antimonopoly Service.

The compulsory licensing of drugs may be used in cases of epidemics or in situations where a company is the sole owner of a drug for a serious disease. In this case, the developer will receive compensation, while other pharmaceutical companies will be allowed to manufacture similar drugs (generics) without violating intellectual property rights.

“We will use (compulsory licensing). The USA used this procedure thousands of times and did it unceremoniously no matter who they were dealing with. But it seems that we are too tactful and therefore still cannot adopt this law. There is a decision of leadership, and this law will be adopted. I think that it will happen as early as this year,” said Mr. Artemyev.

Source

Return